AAAAAA

   
Results: 1-25 | 26-29
Results: 1-25/29
A REVOLUTION IN THE TREATMENT OF NON-HODGKINS-LYMPHOMA
Authors: DENARDO GL ODONNELL RT OLDHAM RK DENARDO SJ
Citation: Gl. Denardo et al., A REVOLUTION IN THE TREATMENT OF NON-HODGKINS-LYMPHOMA, CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 13(4), 1998, pp. 213-223
UNTITLED
Authors: OLDHAM RK
Citation: Rk. Oldham, UNTITLED, CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 13(3), 1998, pp. 141-141
TREATMENT OF DRUG-RESISTANCE - BIOTHERAPY OR CHEMOTHERAPY
Authors: OLDHAM RK
Citation: Rk. Oldham, TREATMENT OF DRUG-RESISTANCE - BIOTHERAPY OR CHEMOTHERAPY, CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 13(2), 1998, pp. 69-70
A PHASE-I AND PHARMACOKINETIC STUDY OF CBT-1 AS A MULTIDRUG-RESISTANCE MODULATOR IN THE TREATMENT OF PATIENTS WITH ADVANCED CANCER
Authors: OLDHAM RK REID WK PREISLER HD BARNETT D
Citation: Rk. Oldham et al., A PHASE-I AND PHARMACOKINETIC STUDY OF CBT-1 AS A MULTIDRUG-RESISTANCE MODULATOR IN THE TREATMENT OF PATIENTS WITH ADVANCED CANCER, CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 13(2), 1998, pp. 71-80
INTERLEUKIN-2 - DOSE, SCHEDULE AND ROUTE
Authors: OLDHAM RK
Citation: Rk. Oldham, INTERLEUKIN-2 - DOSE, SCHEDULE AND ROUTE, CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 12(6), 1997, pp. 363-364
CANCER BIOTHERAPY - WHEN, WHY AND HOW LONG
Authors: OLDHAM RK
Citation: Rk. Oldham, CANCER BIOTHERAPY - WHEN, WHY AND HOW LONG, CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 12(5), 1997, pp. 295-296
THE CANCER-BIOTHERAPY-RESEARCH-GROUP [CBRG], FORMERLY THE NATIONAL-BIOTHERAPY-STUDY-GROUP [NBSG] - A 10-YEAR PERSPECTIVE
Authors: DILLMAN RO CRISPIN R OLDHAM RK
Citation: Ro. Dillman et al., THE CANCER-BIOTHERAPY-RESEARCH-GROUP [CBRG], FORMERLY THE NATIONAL-BIOTHERAPY-STUDY-GROUP [NBSG] - A 10-YEAR PERSPECTIVE, CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 12(4), 1997, pp. 229-242
LONG-TERM SURVIVAL AFTER CONTINUOUS-INFUSION INTERLEUKIN-2
Authors: DILLMAN RO CHURCH C BARTH NM OLDHAM RK WIEMANN MC
Citation: Ro. Dillman et al., LONG-TERM SURVIVAL AFTER CONTINUOUS-INFUSION INTERLEUKIN-2, CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 12(4), 1997, pp. 243-248
REGULATORY HIERARCHIES (REPRINTED FROM MOLECULAR BIOTHERAPY, 1988)
Authors: OLDHAM RK
Citation: Rk. Oldham, REGULATORY HIERARCHIES (REPRINTED FROM MOLECULAR BIOTHERAPY, 1988), CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 12(3), 1997, pp. 137-140
PEER-REVIEW
Authors: OLDHAM RK
Citation: Rk. Oldham, PEER-REVIEW, CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 12(2), 1997, pp. 63-64
CANCER AND DIABETES - ARE THERE SIMILARITIES
Authors: OLDHAM RK
Citation: Rk. Oldham, CANCER AND DIABETES - ARE THERE SIMILARITIES, CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 12(1), 1997, pp. 1-3
INNOVATION IN SCIENCE
Authors: OLDHAM RK
Citation: Rk. Oldham, INNOVATION IN SCIENCE, CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 11(6), 1996, pp. 345-346
PROGRESS IN THE MONOCLONAL-ANTIBODY THERAPY OF CANCER
Authors: OLDHAM RK
Citation: Rk. Oldham, PROGRESS IN THE MONOCLONAL-ANTIBODY THERAPY OF CANCER, CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 11(5), 1996, pp. 279-279
FDA REFORM - REAL OR JUST MORE POLITICS
Authors: OLDHAM RK
Citation: Rk. Oldham, FDA REFORM - REAL OR JUST MORE POLITICS, CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 11(4), 1996, pp. 227-228
GOVERNMENT OVERSIGHT OR WHAT
Authors: OLDHAM RK
Citation: Rk. Oldham, GOVERNMENT OVERSIGHT OR WHAT, CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 11(3), 1996, pp. 165-166
MAGIC BULLETS - DEJA-VU ALL OVER AGAIN
Authors: OLDHAM RK
Citation: Rk. Oldham, MAGIC BULLETS - DEJA-VU ALL OVER AGAIN, CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 11(2), 1996, pp. 97-98
FDA UPDATE - 1996
Authors: OLDHAM RK
Citation: Rk. Oldham, FDA UPDATE - 1996, CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 11(1), 1996, pp. 1-2
BIOTHERAPY AND RADIOPHARMACEUTICALS
Authors: OLDHAM RK
Citation: Rk. Oldham, BIOTHERAPY AND RADIOPHARMACEUTICALS, Cancer biotherapy, 10(4), 1995, pp. 251-251
INTERFERON ALPHA-2A AND EXTERNAL-BEAM RADIOTHERAPY IN THE INITIAL MANAGEMENT OF PATIENTS WITH GLIOMA - A PILOT-STUDY OF THE NATIONAL BIOTHERAPY STUDY-GROUP
Authors: DILLMAN RO WIEMANN M OLDHAM RK SOORI G BURY M HAFER R CHURCH C DEPRIEST C
Citation: Ro. Dillman et al., INTERFERON ALPHA-2A AND EXTERNAL-BEAM RADIOTHERAPY IN THE INITIAL MANAGEMENT OF PATIENTS WITH GLIOMA - A PILOT-STUDY OF THE NATIONAL BIOTHERAPY STUDY-GROUP, Cancer biotherapy, 10(4), 1995, pp. 265-271
CANCER BIOTHERAPY - THE FIELD MATURES
Authors: OLDHAM RK
Citation: Rk. Oldham, CANCER BIOTHERAPY - THE FIELD MATURES, Cancer biotherapy, 10(2), 1995, pp. 91-93
INTERLEUKIN-15 AND THE GROWTH OF TUMOR-DERIVED ACTIVATED T-CELLS
Authors: LEWKO WM SMITH TL BOWMAN DJ GOOD RW OLDHAM RK
Citation: Wm. Lewko et al., INTERLEUKIN-15 AND THE GROWTH OF TUMOR-DERIVED ACTIVATED T-CELLS, Cancer biotherapy, 10(1), 1995, pp. 13-20
THE WAR ON CANCER - NEW BATTLE PLAN NEEDED
Authors: OLDHAM RK
Citation: Rk. Oldham, THE WAR ON CANCER - NEW BATTLE PLAN NEEDED, Cancer biotherapy, 9(4), 1994, pp. 289-290
CANCER BIOTHERAPY - THE FIRST YEAR
Authors: OLDHAM RK
Citation: Rk. Oldham, CANCER BIOTHERAPY - THE FIRST YEAR, Cancer biotherapy, 9(3), 1994, pp. 179-181
GROWTH OF TUMOR-DERIVED ACTIVATED T-CELLS FOR THE TREATMENT OF CANCER
Authors: LEWKO WM GOOD RW BOWMAN D SMITH TL OLDHAM RK
Citation: Wm. Lewko et al., GROWTH OF TUMOR-DERIVED ACTIVATED T-CELLS FOR THE TREATMENT OF CANCER, Cancer biotherapy, 9(3), 1994, pp. 211-224
CANCER-RESEARCH - DOES IT DELIVER FOR THE PATIENT
Authors: OLDHAM RK
Citation: Rk. Oldham, CANCER-RESEARCH - DOES IT DELIVER FOR THE PATIENT, Cancer biotherapy, 9(2), 1994, pp. 99-102
Risultati: 1-25 | 26-29